NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $294,782 | +9.9% | 2,894 | +8.9% | 0.10% | +8.9% |
| Q2 2023 | $268,120 | +20.0% | 2,657 | +9.4% | 0.09% | +12.5% |
| Q1 2023 | $223,468 | -1.2% | 2,429 | -2.6% | 0.08% | -14.0% |
| Q4 2022 | $226,255 | -21.2% | 2,494 | -33.8% | 0.09% | -26.2% |
| Q3 2022 | $287,000 | +31.1% | 3,768 | +45.4% | 0.13% | +40.0% |
| Q2 2022 | $219,000 | -1.4% | 2,592 | +2.6% | 0.09% | +23.3% |
| Q1 2022 | $222,000 | -17.5% | 2,527 | -23.1% | 0.07% | -6.4% |
| Q3 2021 | $269,000 | -0.7% | 3,284 | +10.7% | 0.08% | +1.3% |
| Q2 2021 | $271,000 | -8.4% | 2,967 | -5.4% | 0.08% | -18.9% |
| Q4 2020 | $296,000 | -31.8% | 3,136 | -37.1% | 0.10% | -28.6% |
| Q3 2020 | $434,000 | +86.3% | 4,983 | +86.5% | 0.13% | +41.5% |
| Q2 2020 | $233,000 | – | 2,672 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |